Patents by Inventor Christopher Luckhurst

Christopher Luckhurst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Piperidines as chemokine modulators (CCR)
    Patent number: 7956070
    Abstract: Compounds of formula (I): are modulators of chemokine (for example CCR3) activity (for use in, for example, treating asthma).
    Type: Grant
    Filed: January 31, 2005
    Date of Patent: June 7, 2011
    Assignee: AstraZeneca AB
    Inventors: Lilian Alcaraz, Peter Cage, Mark Furber, Elizabeth Kinchin, Christopher Luckhurst, Aaron Rigby
  • N-Benzyl-Morpholine Derivatives as Modulators of the Chemokine Receptor
    Publication number: 20090118288
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.
    Type: Application
    Filed: July 19, 2006
    Publication date: May 7, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Christopher Luckhurst, Brian Springthorpe
  • Chemical Compounds
    Publication number: 20090118513
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.
    Type: Application
    Filed: January 15, 2009
    Publication date: May 7, 2009
    Applicant: AstraZeneca AB
    Inventors: Moya Caffrey, Christopher Luckhurst, Tobias Mochel, Matthew Perry, Brian Springthorpe
  • Piperidine derivatives useful as modulators of chemokine receptor activity
    Patent number: 7517989
    Abstract: The present invention provides a compound of formula (I), wherein: Z is (A) OR (B) and wherein the remaining variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of achemokine (such as CCR3) or H1 mediated disease state.
    Type: Grant
    Filed: March 17, 2003
    Date of Patent: April 14, 2009
    Assignee: AstraZeneca AB
    Inventors: Christopher Luckhurst, Matthew Perry, Hitesh Sanganee, Brian Springthorpe
  • Piperidine Derivatives Useful as Modulators of Chemokine Receptor Activity
    Publication number: 20090069325
    Abstract: The present invention relates to the compounds of formula (I): in which: and the remaining variables are defined herein. The present invention also relates to a process for preparing such compounds and use of such compounds in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.
    Type: Application
    Filed: November 10, 2008
    Publication date: March 12, 2009
    Applicant: AstraZeneca AB
    Inventors: Christopher Luckhurst, Matthew Perry, Hitesh Sanganee, Brian Springthorpe
  • Chemical compounds
    Patent number: 7495013
    Abstract: The present invention relates to compounds of formula (I): The variables recited in formula (I) are defined in the specification. The present invention also relates to processes of preparing compounds of formula (I) and uses of such compounds for treating a chemokine (e.g., CCR3) or H1 mediated disease state.
    Type: Grant
    Filed: March 30, 2004
    Date of Patent: February 24, 2009
    Assignee: AstraZeneca AB
    Inventors: Moya Caffrey, Christopher Luckhurst, Tobias Mochel, Matthew Perry, Brian Springthorpe
  • Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them
    Publication number: 20090023733
    Abstract: The present invention provides a compound of a formula (I): [Chemical formula should be inserted here. Please see paper copy] wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.
    Type: Application
    Filed: March 6, 2007
    Publication date: January 22, 2009
    Inventors: Peter Cage, Mark Furber, Christopher Luckhurst, Matthew Perry, Brian Springthorpe
  • Novel piperidines as chemokine modulators (ccr)
    Publication number: 20070054924
    Abstract: Compounds of formula (I): are modulators of chemokine (for example CCR3) activity (for use in, for example, treating asthma).
    Type: Application
    Filed: January 31, 2005
    Publication date: March 8, 2007
    Inventors: Lilian Alcaraz, Peter Cage, Mark Furber, Elizabeth Kinchin, Christopher Luckhurst, Aaron Rigby
  • Chemical compounds
    Publication number: 20070032523
    Abstract: The present invention provides a compound of a formula (I) wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.
    Type: Application
    Filed: March 30, 2004
    Publication date: February 8, 2007
    Inventors: Moya Caffrey, Christopher Luckhurst, Tobias Mochel, Matthew Perry, Brian Springthorpe
  • Piperidine derivatives for the treatment of chemokine or h1 mediated disease state
    Publication number: 20060281726
    Abstract: The present invention provides a compound of a formula (I), wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.
    Type: Application
    Filed: March 23, 2004
    Publication date: December 14, 2006
    Inventors: Christopher Luckhurst, Matthew Perry, Brian Springthorpe
  • Chemical compounds
    Publication number: 20060264463
    Abstract: The present invention provides a compound of a formula (1): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.
    Type: Application
    Filed: May 6, 2004
    Publication date: November 23, 2006
    Inventors: Christopher Luckhurst, Tobias Mochel, Matthew Perry, Brian Springthorpe, Linda Stein
  • Novel piperidine derivatives for use in the treatment of chemokine medicated disease states
    Publication number: 20060040984
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.
    Type: Application
    Filed: September 12, 2003
    Publication date: February 23, 2006
    Inventors: Christopher Luckhurst, Matthew Perry, Brian Springthorpe
  • Piperidine derivatives useful as modulators of chemokine receptor activity
    Publication number: 20050176708
    Abstract: The present invention provides a compound of formula (I), wherein: Z is (A:) OR (B) and wherein the remaining variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of achemokine (such as CCR3) or H1 mediated disease state,
    Type: Application
    Filed: March 17, 2003
    Publication date: August 11, 2005
    Inventors: Christopher Luckhurst, Matthew Perry, Hitesh Sanganee, Brian Springthorpe